Related Experiment Videos
PET and brain tumor image fusion
Terence Z Wong1, Timothy G Turkington, Thomas C Hawk
1Department of Radiology, Nuclear Medicine Division, Duke University Medical Center, Durham, North Carolina 27710, USA. wong0015@mc.duke.edu
Cancer Journal (Sudbury, Mass.)
|September 24, 2004
Summary
Positron emission tomography (PET) with (18)F-2-deoxy-2-fluoro-D-glucose (FDG-PET) aids brain tumor evaluation and follow-up. Image registration with MRI is crucial for accurate localization, improving treatment planning.
Area of Science:
- Nuclear medicine
- Radiology
- Neuro-oncology
Background:
- (18)F-2-deoxy-2-fluoro-D-glucose (FDG-PET) is vital for brain tumor assessment and post-therapy monitoring.
- Over 400 brain tumor FDG-PET studies are conducted annually at Duke University Medical Center.
- Accurate localization of brain tumors requires integrating FDG-PET with anatomical imaging like MRI due to metabolic heterogeneity and high normal brain metabolism.
Purpose of the Study:
- To present a semi-automated image registration technique for FDG-PET and MRI in brain tumor patients.
- To highlight the importance of combining functional and anatomical imaging for brain tumor management.
Main Methods:
- Development and routine implementation of a semi-automated image registration technique.
- Utilizing registered FDG-PET and MRI data for brain tumor evaluation.
Main Results:
- A practical semi-automated image registration method is routinely used for all brain tumor patients.
- The technique facilitates accurate localization of brain tumor abnormalities.
Conclusions:
- Image registration is essential for precise localization of brain tumors using FDG-PET.
- Future applications will leverage combined functional/anatomical data for radiation and surgical treatment planning.